Tuberculosis News and Research

Latest Tuberculosis News and Research

Simple TB screening and isoniazid can be effective for HIV patients at risk for TB

The number one killer of HIV patients in resource-limited areas, including parts of Africa and India, is tuberculosis (TB), underscoring the need for optimal treatments and effective strategies to address this deadly co-infection. But TB is harder to detect in HIV-infected patients and diagnostic test results take time, so many healthcare providers prescribe multi-drug TB treatments as a precaution.

20 Mar 2016

Clinical study finds no added benefit of using four TB drugs to save people with advanced HIV/AIDS

In a report on the so-called REMEMBER (Reducing Early Mortality and Early Morbidity by Empiric Tuberculosis Treatment) study -- a 10-nation, randomized clinical trial of adult outpatients -- investigators concluded that there was no added benefit of using four drugs for TB over just using one drug, isoniazid, to save lives in people with advanced HIV/AIDS.

18 Mar 2016

Study: Statin drugs can reduce time to clear tuberculosis infection in mice

In a study using mice, the Johns Hopkins University School of Medicine infectious disease experts have added to evidence that statin drugs — known primarily for their cholesterol-lowering effects — can significantly reduce the time it takes to clear tuberculosis infection.

17 Mar 2016

Low cost, easy-to-use test could help reduce TB death rate of HIV patients in sub-Saharan Africa

A low cost, easy to use, urine test to diagnose tuberculosis (TB) among patients with HIV could help reduce the TB death rate of HIV-positive patients in hospital, according to a new study published in The Lancet today.

10 Mar 2016

HIV-positive individuals in Africa with certain genetic variant have lower chance of developing TB

In the first known discovery of its kind, a Case Western Reserve University School of Medicine-led team has found that HIV patients in Africa with a certain genetic variant have a 63-percent lower chance of developing tuberculosis than HIV patients without the genetic variant.

10 Mar 2016

Stop TB Partnership's new initiative to increase access to two new life-saving TB medicines

The Stop TB Partnership's Global Drug Facility (GDF) will announce a new initiative to increase access to bedaquiline and delamanid - the two new life-saving medicines recently approved for the treatment of multi-drug resistant tuberculosis (TB). The GDF will share how it is expanding existing and developing new public-private partnerships to expedite and maximize access to these two critical medicines.

25 Feb 2016

Discovery could lead to more effective vaccines, personalised therapies for TB

Tuberculosis (TB) used to kill one in seven people around the world before the advent of antibiotics. However the increasing prevalence of multi-drug resistant TB means that doctors are running out of options in trying to combat this bacterium.

18 Feb 2016

Small chemical change to existing antibacterial drug may result in better treatment for TB

Researchers with Vanderbilt University have discovered that one small chemical change to an existing antibacterial drug results in a compound that is more effective against its target enzyme in tuberculosis.

17 Feb 2016

Researchers one step closer to developing new treatment strategy to combat TB

By uncovering the 3-dimensional structure of an enzyme that is critical for the survival of the bacterium that cause tuberculosis, researchers may be one step closer to developing a new strategy to combat TB infections.

17 Feb 2016

NJHF awards 30 grants for NJ researchers working on health-related research

New Jersey Health Foundation has awarded 30 grants totaling more than $1 million for researchers in New Jersey who are working on health-related research that demonstrates exciting potential.

4 Feb 2016

Indoor air quality in hospitality venues that allow smoking is worse than outdoor, study finds

Research carried out in six cities with dangerous levels of air pollution indicates that air quality inside venues that allow smoking is even worse than outdoors.

28 Jan 2016

Vital Strategies launched to improve global health

A new name in global health - Vital Strategies was launched today, with a mission of reducing disease and premature death and helping to deliver a world where every person has the protection of a strong public health system.

27 Jan 2016

Better universal healthcare needed to reduce CHE for low-income TB patients in China

Improved universal healthcare is urgently needed to lower catastrophic health expenditure (CHE) for low-income tuberculosis (TB) patients in China, according to a study published in the open access journal Infectious Diseases of Poverty.

25 Jan 2016

Johnson & Johnson joins industry-wide call to address growing problem of antimicrobial resistance

Johnson & Johnson today announced it has joined more than 80 companies and organizations in signing the Declaration on Combating Antimicrobial Resistance (AMR), an industry-wide call to action announced at the World Economic Forum in Davos, Switzerland.

21 Jan 2016

Researchers suggest ways to make TB drugs more efficacious against mutations

Biophysicists have discovered why the bacteria that cause tuberculosis (TB) are naturally somewhat resistant to antibiotics known as fluoroquinolones. Their findings, based on mapping the detailed three-dimensional structure of the drugs interacting with an essential enzyme in the TB germ, also reveal why some TB drugs are more potent than others and suggest how drug developers can make fluoroquinolones more efficacious against mutations that make the lung disease drug resistant.

19 Jan 2016

Novartis announces FDA approval of Cosentyx for treatment of adult patients with AS and PsA

Novartis announced today that the US Food and Drug Administration has approved Cosentyx (secukinumab) for two new indications - the treatment of adult patients with active ankylosing spondylitis (AS) and active psoriatic arthritis (PsA).

17 Jan 2016

Malaysian scientists join forces with Harvard experts to help revolutionize lung disease treatment

Malaysian scientists are joining forces with Harvard University experts to help revolutionize the treatment of lung diseases -- the delivery of nanomedicine deep into places otherwise impossible to reach.

12 Jan 2016

ISHLT issues new list of criteria to determine patient eligibility for heart transplant

To determine patient eligibility for heart transplant, the International Society for Heart Lung Transplantation maintains a list of criteria, first issued in 2006, that acts as a guideline for physicians.

7 Jan 2016

Researchers identify mechanism that allows cancer cells to grow rapidly when blood sugar levels rise

Researchers have identified a mechanism that allows cancer cells to respond and grow rapidly when levels of sugar in the blood rise. This may help to explain why people who develop conditions in which they have chronically high sugar levels in their blood, such as obesity, also have an increased risk of developing certain types of cancer.

6 Jan 2016

International panel of clinical experts comment on state of their fields

In an Editorial published this week in PLOS Medicine, editors ask an international panel of eleven expert researchers and clinicians spanning a range of specialties to answer questions on their field and what developments they hope and expect to see in 2016.

30 Dec 2015

Tuberculosis News and Research

Latest Tuberculosis News and Research

Simple TB screening and isoniazid can be effective for HIV patients at risk for TB

Clinical study finds no added benefit of using four TB drugs to save people with advanced HIV/AIDS

Study: Statin drugs can reduce time to clear tuberculosis infection in mice

Low cost, easy-to-use test could help reduce TB death rate of HIV patients in sub-Saharan Africa

HIV-positive individuals in Africa with certain genetic variant have lower chance of developing TB

Stop TB Partnership's new initiative to increase access to two new life-saving TB medicines

Discovery could lead to more effective vaccines, personalised therapies for TB

Small chemical change to existing antibacterial drug may result in better treatment for TB

Researchers one step closer to developing new treatment strategy to combat TB

NJHF awards 30 grants for NJ researchers working on health-related research

Indoor air quality in hospitality venues that allow smoking is worse than outdoor, study finds

Vital Strategies launched to improve global health

Better universal healthcare needed to reduce CHE for low-income TB patients in China

Johnson & Johnson joins industry-wide call to address growing problem of antimicrobial resistance

Researchers suggest ways to make TB drugs more efficacious against mutations

Novartis announces FDA approval of Cosentyx for treatment of adult patients with AS and PsA

Malaysian scientists join forces with Harvard experts to help revolutionize lung disease treatment

ISHLT issues new list of criteria to determine patient eligibility for heart transplant

Researchers identify mechanism that allows cancer cells to grow rapidly when blood sugar levels rise

International panel of clinical experts comment on state of their fields

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Tuberculosis News and Research

Latest Tuberculosis News and Research

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in